fda - Search News

News

Inside fall of Vinay Prasad at FDA

Controversial vaccine official Dr. Vinay Prasad departs FDA

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and was later named chief medical and scientific officer.

UPI on MSN · 21h

FDA chief scientific officer Vinay Prasad resigns

Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in the position.

USA TODAY on MSN · 1d

FDA's top vaccine official leaves agency after controversial decisions

Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.

FDA, Opioid

The Week US on MSN · 17h

Why the FDA wants to restrict kratom-related products

The FDA announced that it is urging the Drug Enforcement Agency to "classify 7-OH as a Schedule 1 substance, placing it on a list of drugs that include heroin, lysergic acid diethylamide (LSD) and ecstasy," said The Hill. This would make the drug harder to obtain at locations like gas stations and convenience stores.

U.S. News & World Report · 1d

FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products

A concentrated compound derived from the kratom plant, 7-OH has a great potential for abuse. The agency is not focusing on natural kratom leaf products. A new report issued by the FDA aims to inform the public about the health risks of 7-OH and to clarify how it differs from the kratom leaf.

Yahoo · 15h

FDA urges crackdown on 7-OH, a potent opioid-like substance

Federal health officials are calling for urgent action against a powerful, unregulated substance being sold in gas stations, vape shops, and convenience stores across the country.

12m

FDA Issues Risk Warning for Aldi Churro Recall in 13 States

Camerican International, Inc. issued a voluntary recall of Casa Mamita Churro Bites due to a potential undeclared allergen.

The American Journal of Managed Care5m

FDA Recommends Sarepta Resume DMD Gene Therapy Shipments for Ambulatory Patients

Shipment of delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), will resume following a ...

23h

Top FDA vaccine regulator abruptly exits post

DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...

Phoenix New Times16m

FDA recommends ban of potent 7-OH kratom variant

The synthetic variant is legal and has opioid-like effects. One official called it “a recipe for a public safety disaster.” ...

MedPage Today on MSN2d

New FDA Drug Chief: 'Revolving Door' or Reformer?

The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...

Fierce Pharma36m

Vinay Prasad's exit signals FDA's probable slip toward more permissive regulation of cell and gene therapy: analyst

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

FDA seeks controlled substance status for potent synthetic opioid sold in gas stations

The FDA recommended classifying 7-OH as a Schedule I controlled substance due to its opioid-like effects and its use in unregulated products.

13hon MSN

Trump drove firing of FDA official

The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Inside fall of Vinay Prasad at FDA

FDA, Opioid

Related topics